Medication Adherence and Outcomes Among Patients in United States With HIV

Completed · Not applicable

Conditions studied: Human Immunodeficiency Virus, Medication Adherence

In brief

With support from the NIH, this pilot study will assess the feasibility of using wireless devices and financial incentives to motivate medication adherence among HIV-positive adults in the U.S., focusing on those with non-suppressed viral loads. While daily lotteries using wireless devices may have great potential for improving adherence to ART regimens, substantial questions exist as to whether it is: 1) possible to achieve high rates of uptake for a pilot offering wireless devices to high-risk populations; 2) achieve high rates of sustained engagement.

Key facts

Study ID

NCT03995745

Run by

University of Pennsylvania

People needed

40

Starts

2019-05-16

Expected to finish

2020-10-13

Last updated by the study team

2020-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of HIV, established in 2017 or earlier
• Patients at least 18 years of age or older
• Currently prescribed first or second line ART medications
• Non-suppressed viral loads, with two consecutive non-suppressed viral loads (VL>400 copies/ml) for the past two lab readings.

You may not qualify if…

• Pregnant
• Prescribed Maraviroc or Fuzeon
• More than 5 additional medications
• Diagnosed with insulin dependent diabetes
• Unable to provide consent
• Non-English speaker
• Cognitive impairment, per PI discretion
• Does not have stable residence

Where it is running

• Drexel University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.